People: CASI Pharmaceuticals Inc (CASI.OQ)
Mr. George Chi is Chief Financial Officer of the Company. Mr. Chi joined the Company in October 2018 as Chief Financial Officer. Prior to joining the Company, Mr. Chi was Vice President of Finance at Flavors Holdings where he led the global accounting function, including financial reporting, planning, treasury, investor relations, tax and auditing with global sales in 90 countries. Prior to Flavor Holdings, from 2014-2016, he was Chief Financial Officer at BPL Plasma delivering 60% sales growth and 300% EBITDA growth for a $180 million business. He consolidated business and finance operations to prepare for an IPO where the business was sold at four times the investment in three years. From 2008-2013, he was finance director at Unilever where he was responsible for leading the accounting function including financial reporting, annual budgeting and strategic planning for a $10 billion business across 12 categories. He also successfully managed a $12 billion debt portfolio and coordinated with investment banks for annual debt issuance and repayment. Mr. Chi holds a bachelor’s degree in engineering from Tsinghua University, Beijing, China and a M.B.A. in finance and operations from the Yale School of Management. He also holds certifications as a CPA, CFA from Stanford University Risk Management.
|Total Annual Compensation, USD||76,250|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,316,890|
|Fiscal Year Total, USD||1,393,140|